Health
New drug could improve life expectancy and quality for pancreatic cancer patients – Medical Xpress
The Sheffield researchers founded the spin-out Modulus Oncology with a team of experienced biotech entrepreneurs to fast-track the drug into clinical testing within two years.
The Sheffield researchers founded the spin-out Modulus Oncology with a team of experienced biotech entrepreneurs to fast-track the drug into clinical testing within two years.
A new drug which could improve life expectancy and quality for patients with hard-to-treat cancers, such as pancreatic cancer and relapsed breast cancer, has been invented by scientists at the University of Sheffield.
The researchers founded the spin-out company Modulus Oncology, along with a team of experienced biotech …
-
General21 hours agoByford rail extension opening marks final stage of Perth Metronet
-
General22 hours agoMango the muster cat draws attention to western Queensland’s ongoing recovery
-
General14 hours agoAustralia’s Diamonds defeat South Africa’s Proteas 65-42 in third netball Test
-
Noosa News18 hours ago$20 million program to help women return to work